Premium Membership - Holiday Season Special - 75% off

investorscraft@gmail.com

Investor's Craft

Stock Screeners
Stock Indices
Stock Valuation

Intrinsic Value of Arrowhead Pharmaceuticals, Inc. (ARWR)

Previous Close$18.57
Intrinsic Value$2.22
Upside potential  -88%
Previous Close
$18.57
Intrinsic Value
$2.22
Potential        
-88%

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2023-09-30 and quarterly data as of 2023-06-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

Intrinsic Value Stock Screener
Artificial intelligence value of

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2024202520262027202820292030203120322033203420352036203720382039204020412042204320442045204620472048

INCOME STATEMENT

Revenue growth rate, %-1.0NaN
Revenue, $241NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m446NaN
Operating income, $m-205NaN
EBITDA, $m-195NaN
Interest expense (income), $mNaN
Earnings before tax, $m-202NaN
Tax expense, $m3NaN
Net income, $m-205NaN

BALANCE SHEET

Cash and short-term investments, $m404NaN
Total assets, $m766NaN
Adjusted assets (=assets-cash), $m362NaN
Average production assets, $m211NaN
Working capital, $m314NaN
Total debt, $m0NaN
Total liabilities, $m478NaN
Total equity, $m287NaN
Debt-to-equity ratio0.000NaN
Adjusted equity ratio-0.322NaN

CASH FLOW

Net income, $m-205NaN
Depreciation, amort., depletion, $m10NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-154NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-177NaN
Free cash flow, $m23NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m314
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount